No Influence of DTNBP1 Polymorphisms on the Response to Aripiprazole | Zendy

ChiUn Pae | Zendy; Alberto Chiesa | Zendy; Laura Mandelli | Zendy; Alessandro Serretti | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

No Influence of DTNBP1 Polymorphisms on the Response to Aripiprazole

Author(s) -

ChiUn Pae,

Alberto Chiesa,

Laura Mandelli,

Alessandro Serretti

Publication year - 2010

Publication title -

neuropsychobiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.71

H-Index - 83

eISSN - 1423-0224

pISSN - 0302-282X

DOI - 10.1159/000320863

Subject(s) - aripiprazole , single nucleotide polymorphism , psychology , pharmacogenetics , haplotype , rating scale , akathisia , medicine , schizophrenia (object oriented programming) , psychiatry , genotype , antipsychotic , genetics , biology , developmental psychology , gene

The aim of the present study was to investigate possible influences of a panel of markers in the dysbindin gene DTNBP1 (rs3213207, rs1011313, rs2005976, rs760761 and rs2619522) on the clinical outcome and side effects associated to the treatment with aripiprazole in schizophrenic patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research